A paperfluidic platform to detect Neisseria gonorrhoeae in clinical samples

ABSTRACTGlobally, the microbe Neisseria gonorrhoeae (NG) causes 106 million newly documented sexually transmitted infections each year. Once appropriately diagnosed, NG infections can be readily treated with antibiotics, but high-risk patients often do not return to the clinic for treatment if results are not provided at the point of care. A rapid, sensitive molecular diagnostic would help increase NG treatment and reduce the prevalence of this sexually transmitted disease. Here, we report on the design and development of a rapid, highly sensitive, paperfluidic device for point-of-care diagnosis of NG. The device integrates patient swab sample lysis, nucleic acid extraction, thermophilic helicase-dependent amplification (tHDA), an internal amplification control (NGIC), and visual lateral flow detection within an 80 min run time. Limits of NG detection for the NG/NGIC multiplex tHDA assay were determined within the device, and clinical performance was validated retroactively against qPCR-quantified patient samples in a proof-of-concept study. This paperfluidic diagnostic has a clinically relevant limit of detection of 500 NG cells per device with analytical sensitivity down to 10 NG cells per device. In triplicate testing of 40 total urethral and vaginal swab samples, the device had 95% overall sensitivity and 100% specificity, approaching current laboratory-based molecular NG diagnostics. This diagnostic platform could increase access to accurate NG diagnoses to those most in need.

[1]  P. Yager,et al.  A rapid, instrument-free, sample-to-result nucleic acid amplification test. , 2016, Lab on a chip.

[2]  Federico Girosi,et al.  Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics , 2006, Nature.

[3]  S. Garland,et al.  Neisseria gonorrhoeae DNA bacterial load in men with symptomatic and asymptomatic gonococcal urethritis , 2017, Sexually Transmitted Infections.

[4]  M. Peeters,et al.  Clinical algorithms for the screening of pregnant women for STDs in Libreville, Gabon: which alternatives? , 1998, Sexually transmitted infections.

[5]  J. Papp,et al.  Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. , 2014, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[6]  R. Brotman,et al.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. , 2011, The Journal of clinical investigation.

[7]  Robert E. Johnson,et al.  Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections -- 2002 , 2002 .

[8]  G. Wendel,et al.  Rapid diagnostic methods in sexually transmitted infections. , 2008, Infectious disease clinics of North America.

[9]  R. Peeling,et al.  Advancing prevention of sexually transmitted infections through point-of-care testing: target product profiles and landscape analysis , 2017, Sexually Transmitted Infections.

[10]  D. Fleming,et al.  From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. , 1999, Sexually transmitted infections.

[11]  Mark H. Ellisman,et al.  Alterations in mGluR5 Expression and Signaling in Lewy Body Disease and in Transgenic Models of Alpha-Synucleinopathy – Implications for Excitotoxicity , 2010, PloS one.

[12]  S. Kraus,et al.  Quantitation of Neisseria gonorrhoeae from women with gonorrhea. , 1976, The Journal of infectious diseases.

[13]  L. Anand,et al.  Thermal bonding of microfluidic devices : factors that affect interfacial strength of similar and dissimilar cyclic olefin copolymers , 2012 .

[14]  C. Gaydos,et al.  Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae , 2013, Journal of Clinical Microbiology.

[15]  Bertrand Lemieux,et al.  Paper-based molecular diagnostic for Chlamydia trachomatis. , 2014, RSC advances.

[16]  C. Klapperich,et al.  Polyethersulfone improves isothermal nucleic acid amplification compared to current paper-based diagnostics , 2016, Biomedical microdevices.

[17]  M. Unemo,et al.  The porA pseudogene of Neisseria gonorrhoeae– low level of genetic polymorphism and a few, mainly identical, inactivating mutations , 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[18]  M. Cole,et al.  Prevalence of porA pseudogene deletion among Neisseria gonorrhoeae isolates referred to the UK's Gonococcal Resistance to Antimicrobials Surveillance Program. , 2017, Sexual health.

[19]  J. Wasserheit,et al.  Epidemiological Synergy: Interrelationships between Human Immunodeficiency Virus Infection and Other Sexually Transmitted Diseases , 1992, Sexually transmitted diseases.

[20]  R. Peeling,et al.  Evaluation of a rapid point-of-care test for the detection of gonococcal infection among female sex workers in Benin , 2006, Sexually Transmitted Infections.

[21]  J. P. Dillard Genetic Manipulation of Neisseria gonorrhoeae , 2011, Current protocols in microbiology.

[22]  L. Gervais,et al.  Toward one-step point-of-care immunodiagnostics using capillary-driven microfluidics and PDMS substrates. , 2009, Lab on a chip.

[23]  Rajan Dewar,et al.  A fully integrated paperfluidic molecular diagnostic chip for the extraction, amplification, and detection of nucleic acids from clinical samples. , 2016, Lab on a chip.

[24]  Maliha Aziz,et al.  The Effects of Circumcision on the Penis Microbiome , 2010, PloS one.

[25]  C. Klapperich,et al.  Sample preparation module for bacterial lysis and isolation of DNA from human urine , 2009, Biomedical microdevices.

[26]  R. Peeling,et al.  Performance and operational characteristics of point-of-care tests for the diagnosis of urogenital gonococcal infections , 2017, Sexually Transmitted Infections.

[27]  Jill S. Huppert,et al.  What Is the Point? How Point-of-care Sexually Transmitted Infection Tests Can Impact Infected Patients , 2010 .